Andere talen 9 Meters Biopharma, Inc.

Aandelen

Beurs gesloten - OTC Markets Andere beurzen 20:56:29 29-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,000001 ^USD	0,00%		0,00%	0,00%

2023	Illumina verlaagt jaarwinstprognose omdat financieringsproblemen biotech aanhouden	RE
2023	Illumina verlaagt jaarlijkse winstverwachting	RE

North American Morning Briefing : Tech in Focus on -2-	25/03
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11
North American Morning Briefing : Stocks Look to -2-	06/11
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11
Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	02-10-23
North American Morning Briefing : Stock Futures -2-	22-09-23
North American Morning Briefing : Mood Seen Buoyed -2-	15-09-23
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08-09-23
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01-09-23
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25-08-23
North American Morning Briefing : China Trouble Hits Sentiment	18-08-23
North American Morning Briefing : Stock Futures -2-	11-08-23
Illumina cuts annual profit forecast as biotech funding woes linger	09-08-23
Illumina cuts annual profit forecast	09-08-23
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25-07-23
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21-07-23
Drug developer 9 Meters Biopharma files for bankruptcy protection	18-07-23
9 Meters Biopharma, Inc. Filed for Bankruptcy	17-07-23

Geen resultaten voor deze zoekopdracht